Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer

…, T Karn, C Liedtke, D Mauri, R Rouzier… - Annals of surgical …, 2012 - Springer
The use of neoadjuvant systemic therapy (NST) for the treatment of primary breast cancer
has constantly increased, especially in trials of new therapeutic regimens. In the 1980 s …

Breast cancer in pregnancy: recommendations of an international consensus meeting

…, N Ottevanger, S Pans, F Peccatori, R Rouzier… - European journal of …, 2010 - Elsevier
PURPOSE: To provide guidance for clinicians about the diagnosis, staging and treatment of
breast cancer occurring during an otherwise uncomplicated pregnancy. METHODS: An …

Taxanes for breast cancer during pregnancy: a systematic review

…, R Serreau, F Goldwasser, R Rouzier - Annals of …, 2010 - annalsofoncology.org
The co-occurrence of breast cancer and pregnancy is an important issue for the forthcoming
years, given the trend for women to postpone childbearing [1]. Although the use of …

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

R Rouzier, CM Perou, WF Symmans, N Ibrahim… - Clinical cancer …, 2005 - AACR
Purpose: Molecular classification of breast cancer has been proposed based on gene
expression profiles of human tumors. Luminal, basal-like, normal-like, and erbB2+ …

[HTML][HTML] A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH

…, L Vonghia, R Rouzier… - … England Journal of …, 2021 - Mass Medical Soc
Background Management of nonalcoholic steatohepatitis (NASH) is an unmet clinical need.
Lanifibranor is a pan-PPAR (peroxisome proliferator–activated receptor) agonist that …

[PDF][PDF] Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer

…, AU Buzdar, PJ Dempsey, R Rouzier… - Journal of clinical …, 2006 - Citeseer
Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and
Fluorouracil, Doxorubicin, and Cycloph Page 1 Pharmacogenomic Predictor of Sensitivity to …

Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer

R Rouzier, R Rajan, P Wagner… - Proceedings of the …, 2005 - National Acad Sciences
Breast cancers show variable sensitivity to paclitaxel. There is no diagnostic test to identify
tumors that are sensitive to this drug. We used U133A chips to identify genes that are …

[PDF][PDF] Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer

…, M Carcangiu, D Watson, P Valagussa, R Rouzier… - J Clin Oncol, 2005 - academia.edu
Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to
Chemotherapy in Women With Locally Advanced Page 1 Gene Expression Profiles in …

Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO)

…, D Querleu, F Golfier, E Leblanc, R Rouzier… - The lancet …, 2011 - thelancet.com
Background Retrospective single-centre series have shown the feasibility of sentinel lymph-
node (SLN) identification in endometrial cancer. We did a prospective, multicentre cohort …

[HTML][HTML] Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep …

M Bazot, C Lafont, R Rouzier, G Roseau… - Fertility and sterility, 2009 - Elsevier
OBJECTIVE: To compare the value of physical examination, transvaginal sonography (TVS),
rectal endoscopic sonography (RES), and magnetic resonance imaging (MRI) for the …